Tagrisso
- Strength
- 80mg
- Manufacturer
- AstraZeneca
- Availability
- Available to source
Ask for price
Osimertinib 80mg — Tablet, 30's Strip
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
Tagrisso uses and dosage
Tagrisso (Osimertinib), is a prescription medicine used to treat advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Tagrisso manufactured by AstraZeneca Pharma Ltd. In India. Osimertinib has to take orally once daily with or without food.
Indications
Lung cancer
Tagrisso side effects
The most common adverse reactions (≥25%) of Osimertinib are: Diarrhea, rash, dry skin, nail toxicity, stomatitis and reduced appetite.
- Originator brand
- Tagrisso by AstraZeneca
- Made by
- AstraZeneca
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
